ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNGO vs MRK // FREE CASH FLOW YIELD

Bionano Genomics Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BNGO 0 — MRK 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNGO VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNGO MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 46.30% 74.80% -28.50 MRK /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 20.70% -55.70 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — 3.42% — TIE /fcf-yield <GO>
Operating Margin -60.00% 34.30% -94.30 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) -7.40% 1.30% -8.70 MRK /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 7/9 -3.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.3 51.7 -11.40 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.8M $361.02B -$361.00B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNGO REV MRK REV BNGO GROSS % MRK GROSS % BNGO FCF MRK FCF
FY 2025 $28.5M $65.01B 46.3% 74.8% -$16.3M $12.36B
FY 2024 $30.8M $64.17B 1.2% 76.3% -$68.9M $18.10B
FY 2023 $36.1M $60.12B — — -$125.2M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNGO // BETA —
MRK // BETA 0.92